Garner Asset Management Corp Novo Nordisk A S Transaction History

Garner Asset Management Corp

  • $225 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$122.71 - $146.91 $981 - $1,175
-8 Reduced 0.51%
1,572 $224,000
Q4 2023

Feb 14, 2024
BUY
$87.78 - $105.45 $138,692 - $166,611
1,580 New
1,580 $163,000
Q1 2023

May 15, 2023
BUY
$132.34 - $159.14 $181,305 - $218,021
1,370 New
1,370 $218,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Garner Asset Management Corp Portfolio

Follow Garner Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garner Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Garner Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email